Building Emotional Self-Awareness Teletherapy (BEST)
BEST
2 other identifiers
interventional
40
1 country
1
Brief Summary
To examine the feasibility, acceptability, and preliminary efficacy of a remotely delivered intervention for civilians and service members with mild traumatic brain injury (mTBI) who have difficulty recognizing and regulating their emotions. Post-treatment outcomes of interest include emotional self-awareness and regulation, resiliency, and affective symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2022
CompletedFirst Posted
Study publicly available on registry
November 21, 2022
CompletedStudy Start
First participant enrolled
February 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2025
CompletedApril 1, 2025
March 1, 2025
2.1 years
November 14, 2022
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Toronto Alexithymia Scale-20 (TAS-20)
This is a 20-item self report questionnaire comprised of three sub-constructs (Difficulty Identifying feelings, Difficulty Describing feelings, Externally-oriented Thinking). The full scale range is 20-100 (higher scores indicate higher (worse) alexithymia). Subscales are summed to compute a total score.
Baseline, Week 6, Week 12, Week 24
Secondary Outcomes (2)
Change in Levels of Emotional Awareness Scale (LEAS)
Baseline, Week 6, Week 12, Week 24
Change in Difficulty with Emotion Regulation Scale (DERS)
Baseline, Week 6, Week 12, Week 24
Other Outcomes (22)
Change in Brief Resilience Scale (BRS)
Baseline, Week 6, Week 12, Week 24
Change in Positive and Negative Affect Schedule (PANAS)
Baseline, Week 6, Week 12, Week 24
Change in Patient Health Questionnaire-9 (PHQ-9)
Baseline, Week 6, Week 12, Week 24
- +19 more other outcomes
Study Arms (1)
Treatment
EXPERIMENTAL8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes.
Interventions
8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes
Eligibility Criteria
You may qualify if:
- Mild TBI (determined by Ohio State University TBI Identification Method)
- ≥18 years old
- ≥6 months post-TBI
- elevated alexithymia and emotion dysregulation (defined by \>.5 standard deviation above means on the TAS-20 and DERS)
- capacity to consent
- proficient English
- if on medications that influence affect, must be stable for at least 6 weeks
- access to a device capable of video conferencing and high speed internet.
You may not qualify if:
- Premorbid neurological disorder other than TBI (e.g., stroke), active or uncontrolled major psychiatric disorder and/ or disorder that would pose a safety concern (e.g., borderline personality disorder)
- degenerative neurologic condition
- visual, hearing, communication, or cognitive impairments that would impede participation
- unstable or anticipated medication changes that will influence mood/ affect during study participation
- active involvement in an intensive rehabilitation program
- individuals who recently started psychotherapy (e.g., \< 3 months ago)
- participant behaviors that cause concern for their ability to participate in accordance with the study requirements and protocol (e.g., unreliable correspondences, no-shows, no-replies to multiple contacts, habitual rescheduling, unable to complete study requirements in timely manner)
- participants will be excluded if at any point, they participated in TREAT (in-person clinical trial of BEST - NCT03414463)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- National Intrepid Center of Excellencecollaborator
- Congressionally Directed Medical Research Programscollaborator
Study Sites (1)
Indiana University
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Flora Hammond, MD
Indiana University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair of Department of Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
November 14, 2022
First Posted
November 21, 2022
Study Start
February 23, 2023
Primary Completion
March 13, 2025
Study Completion
March 25, 2025
Last Updated
April 1, 2025
Record last verified: 2025-03